GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,148 | -4,630 | -3,188 | -2,069 | -968 |
| Depreciation Amortization | 110 | 440 | 386 | 276 | 156 |
| Accounts receivable | 123 | 567 | 333 | 405 | 309 |
| Accounts payable and accrued liabilities | -111 | -501 | -566 | -651 | -668 |
| Other Working Capital | 33 | 230 | -323 | -90 | -70 |
| Other Operating Activity | -12 | 14 | 233 | 246 | 359 |
| Operating Cash Flow | $-1,005 | $-3,880 | $-3,125 | $-1,883 | $-882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -160 | -123 | -55 | -37 |
| Other Investing Activity | -2 | -140 | -82 | -60 | -37 |
| Investing Cash Flow | $-6 | $-300 | $-205 | $-115 | $-74 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7 | -40 | -34 | -26 | -5 |
| Common Stock Issued | N/A | 5,868 | 5,868 | 5,868 | 4,466 |
| Other Financing Activity | 0 | -368 | -75 | -75 | -75 |
| Financing Cash Flow | $-7 | $5,460 | $5,759 | $5,767 | $4,386 |
| Exchange Rate Effect | N/A | -7 | -15 | 6 | -14 |
| Beginning Cash Position | 2,059 | 780 | 789 | 789 | 789 |
| End Cash Position | 1,041 | 2,050 | 3,203 | 4,564 | 4,205 |
| Net Cash Flow | $-1,018 | $1,270 | $2,414 | $3,775 | $3,416 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,005 | -3,880 | -3,125 | -1,883 | -882 |
| Capital Expenditure | -4 | -160 | -123 | -55 | -37 |
| Free Cash Flow | -1,009 | -4,040 | -3,248 | -1,938 | -919 |